Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Neelam Mukherjee, Niannian Ji, Vincent Hurez, Tyler J. Curiel, Maureen O. Montgomery, Andrew J. Braun, Marlo Nicolas, Marcela Aguilera, Dharam Kaushik, Qianqian Liu, Jianhua Ruan, Kerri A. Kendrick, Robert S. Svatek
Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36492-36502
Hazel Anne Rogers, Rebecca Chapman, Holly Kings, Julie Allard, Jodie Barron-Hastings, Kristian W. Pajtler, Martin Sill, Stefan Pfister, Richard Guy Grundy
Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36530-36541
Mamoru Shoji, Wei Ping Qian, Ganji Purnachandra Nagaraju, Daniel J. Brat, Danielle Pessolano, Rick Luzietti, Spandan Chennamadhavuni, Masayoshi Yamaguchi, Lily Yang, Dennis C. Liotta
Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36102-36109